BlackRock Amends Personalis Stake, Maintains Significant Holding
Ticker: PSNL · Form: SC 13G/A · Filed: Jan 26, 2024 · CIK: 1527753
| Field | Detail |
|---|---|
| Company | Personalis, Inc. (PSNL) |
| Form Type | SC 13G/A |
| Filed Date | Jan 26, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock still owns a big chunk of Personalis, signaling institutional confidence.**
AI Summary
BlackRock, Inc. filed an amended SC 13G/A on January 26, 2024, disclosing its ownership in Personalis, Inc. as of December 31, 2023. This amendment, the fourth for BlackRock regarding Personalis, indicates that BlackRock continues to hold a significant stake in the medical laboratories company. This matters to investors because BlackRock is a major institutional investor, and its continued holding suggests a long-term belief in Personalis's prospects, potentially signaling stability or future growth to other shareholders.
Why It Matters
BlackRock's continued substantial ownership in Personalis, Inc. signals confidence from a major institutional investor, which can influence market perception and investor sentiment for the stock.
Risk Assessment
Risk Level: low — This filing is an update on an existing passive investment, indicating no immediate change in control or significant new risks.
Analyst Insight
Investors should note BlackRock's continued passive stake as a sign of institutional confidence, but also recognize this is a routine update and not an active investment change. Further research into Personalis's fundamentals is warranted.
Key Players & Entities
- BlackRock, Inc. (company) — the reporting person and institutional investor
- Personalis, Inc. (company) — the subject company, a medical laboratories firm
- December 31, 2023 (date) — the date of the event requiring the filing
- January 26, 2024 (date) — the filing date of the SC 13G/A amendment
- 71535D106 (other) — the CUSIP number for Personalis, Inc. Common Stock
Forward-Looking Statements
- BlackRock will maintain a significant, passive stake in Personalis, Inc. for the foreseeable future. (BlackRock, Inc.) — medium confidence, target: December 31, 2024
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as indicated by 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 4)'.
Who is the reporting person in this filing?
The reporting person is BlackRock, Inc., as stated under '(1)Names of reporting persons. BlackRock, Inc.'.
What is the subject company of this filing?
The subject company is Personalis, Inc., identified under 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Personalis, Inc.'.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023, as explicitly stated in the filing.
What is the CUSIP number for the securities discussed?
The CUSIP number for the Common Stock of Personalis, Inc. is 71535D106, as listed under '(CUSIP Number) 71535D106'.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 26, 2024 regarding Personalis, Inc. (PSNL).